Author name: Tony Laughton

We Don’t Want Druggies in our Surgery
Cracking Addiction, Global Awareness, Healthcare, MedHeads

We Don’t Want Druggies in our Surgery

We Don’t Want Druggies in our Surgery

Yesterday I attended GPCE at Melbourne.
I had the opportunity of discussing buprenorphine based pharmacotherapy with a bunch of my GP colleagues. One GP came up and took a handful of sweets from the table at which I was sitting and then said to me, “I don’t want druggies at my surgery.” Before I could reply, he walked off. This is what I wanted to say to him.

Most patients with substance use disorder are grateful for the help that I give them. I would challenge anyone to spot the “druggy” sitting in my waiting room. My surgery has a zero tolerance policy towards violence and aggression. In the last twelve months I have “expelled” three people from my surgery for this kind of behaviour.

First was a woman who threatened me with legal action because I refused to agree to stop prescribing her mother diazepam to treat a new diagnosis of serotonin syndrome. Second was a woman who referred to my Vietnamese physiotherapy colleague as a “Monkey” Third was an elderly lady whom I had reported to Vic Roads.

She subsequently failed an occupational driving test and lost her licence. She came back to my clinic and berated me and accused me of deliberately lying on my original referral to Vic roads. She then threatened me with regulatory referrals.

None of these people were druggies.

The patients with substance use disorder that that I look after continue to to sit quietly in my waiting room and continue to express gratitude for the help that I am able to give them.

Opioid weaning
Cracking Addiction, Global Awareness, Healthcare

Opioid weaning

Just as “No man is an island entire of itself” (John Donne), so too is no prescriber an island.

You’ve decided to start prescribing MATOD. You’ve decided to start prescribing either Suboxone or methadone. Great. Very soon you will develop a following of patients who will become dependent on your prescription, your signature and perhaps most importantly, you. If you get sick or go on holiday, and don’t manage your absence properly, the lives of your patients could be put into turmoil. Furthermore if you work in a group practice your practice colleagues will need to pick up the pieces in your absence.

What if they are not MATOD trained? What if they are “anti-druggies?” Not everyone is as enlightened as you are, not everyone wants to help the most vulnerable people in our society.

Because you cannot operate in isolation, because you cannot prescribe in isolation it behoves you to establish good working relationships with your colleagues so that in the event of any absence, planned for unplanned, then at least some form of agreement can be made in principle regarding the management of your patients.

At the very least any doctor who has access to your patient record can act as your Locum and can theoretically continue a pharmacotherapy prescription – even without training. Of course Ideally, any Locum you engage or any other doctor in your practice who is prepared to manage your patients when you are away, should be trained in pharmacotherapy.

So just as you have a duty to engage with your colleagues in order to arrange Locum cover, so too should your colleagues acknowledge your expertise skills and attitudes to your patients. I have heard too often stories of GPs who have undergone special training to prescribe pharmacotherapy, who have gone back to their surgeries and told everyone the good news that they want to engage in this line of work, only to be told by the “Senior Partner” or the practice manager, that the surgery doesn’t do drug addicts.

Please, I urge all surgeries and colleagues to facilitate and encourage any doctor who wants to prescribe pharmacotherapy. By nurturing this skill, your surgery will be better able to meet the combined challenges of prescription opioid dependence and real time prescription monitoring.

Whether you like it or not the tide is coming in, these issues will affect us all, and it is better to have a pharmacotherapy prescriber on your team: imagine having to cope with these challenges without such talent batting on your team.

Heart and Pills
Global Awareness, Healthcare, MedHeads

High dose opioids kill people

High dose opioids kill people

Ome > 100 = 7*rod

The above mathematical formula can be translated as follows.

Patients suffering from chronic non-cancer pain who are on doses of opioid analgesics that exceed the equivalent of morphine 100 mg daily are potentially seven times more likely to die than those not taking opioids to manage their pain.

What is OME?

OME is the oral morphine equivalent: it is an estimate of the potency of the opioid as compared to morphine. For example, oxycodone at a dose of about 60 mg daily is equivalent to morphine 100 mg daily.

What is 7*ROD?

This means seven times higher risk of death.

This is a wake-up call to us all. As doctors we can no longer simply escalate the dose of opioids for our patients who suffer from chronic pain: we cannot chase the pain with opioids as we may have done in the past. We have to focus on patient safety and, in the first instance we need to act to minimise this risk of death. Secondly, we must be cognisant of the other risks associated with long term opioid therapy including the endocrine side effects of adrenal suppression and sexual dysfunction. Not many of our male patients are aware that opioids can cause erectile dysfunction, loss of libido and infertility.

Opioid weaning is now recommended for patients who are on doses of opioids that exceed the 100 mg morphine equivalent per day. The recommended rates vary but are around the 10 percent per week mark. Opioid weans are fraught with angst, especially in those patients that suffer from depression, present with high pain scores, or are already on very high doses of opioids. Nonetheless we cannot ignore the brutal reality of the situation. These are the very patients we should be weaning off opioids for one very important reason: their elevated risk of death

Question
Cracking Addiction, Global Awareness, Healthcare

Prescription Opioid Crisis

Prescription Opioid Crisis

I have just started using SafeScript. This is the Victorian Department of Health’s response to the current prescription opioid crisis.

I think it is fabulous. Even though it is not yet mandatory in my area, I am nonetheless able to access the service online. It has thrown up some interesting challenges.

For instance I have a female patient with a relatively new diagnosis of seronegative arthritis. She is embarking upon her journey into biological therapies. She also loves her endone. I have been a bit uneasy in dishing it out, but I have rationalised that she has a proven arthritis syndrome, she is already under the care of pain specialists who have recommended clonidine which she takes. So what the harm?

That is until now. I have just seen her SafeScript record. We have all been doing it, my other colleagues and I. We have all been feeling sorry for her and we have all been giving her endone scripts. It has mounted up.

Thanks to SafeScript I can now see that she is getting the equivalent of 50 mg daily of endone. The information was there all along had I chosen to look carefully at it, however now with SafeScript it has been presented to me in an easily digestible format with red alarms all over it. I now have to do something about it.

I have a difficult conversation ahead of me, but at least I now know the facts.

I Just Need a Script
Cracking Addiction, Global Awareness, Healthcare, MedHeads

I Just Need a Script

I just need a script

She breezed in saying those words I dread, “I just need a script”.

I had never seen her before.

I looked at her prescription record. She was on mirtazapine 15 mg nocte and sertraline 100 mg mane. That’s ok, I thought. Then I saw the Panadeine Forte.

So I printed off the antidepressants and smiled sweetly at her.

“Is everything going well?”

“yes, she said, apart from my dental pain. I have just been told I need dental surgery, and the waiting list is nine months. So I need my Panadeine Forte as well.”

My heart sank.

“It’s the only thing that works for me, I have tried everything else, and Dr… always gives me some.”

“Have you tried anti-inflammatories in combination with regular Panadol?”

“Yes, of course, I have. Nothing else works for my pain except Panadeine Forte, I have tried Nurofen, and that upsets my tummy.”

What started as a “quick script” consult turned into a twenty-minute discussion during which I told her the following.

The efficacy of codeine is dependent on its conversion to morphine.

The RACGP does not recommend the use of codeine for non-traumatic dental pain.

Opioids, including codeine, have no evidence of benefit beyond three months.

Opioids, including codeine, have plenty of evidence of harms in the long term, including dependency.

Her history of depression and her personal circumstances were risk factors for aberrant behaviour and ware relative contra-indications to long-term opioid use.

If an upset stomach was the only thing preventing her from using anti-inflammatories, then concomitant use of Nexium would protect her stomach and facilitate the use of an NSAID.

I ended the consultation by suggesting that she might benefit from a powerful NSAID. I suggested meloxicam; I told her that the vet had given my dog meloxicam for her post-operative hysterectomy pain. It had worked for Millicent; perhaps it might work for chronic dental pain in humans.

She left clutching her scripts for antidepressants and a new script for meloxicam 15 mg daily and Nexium 20 mg daily.

I wonder if she will see Dr… soon for a refill of her Panadeine Forte. It will be interesting to see what will happen when Safescript becomes mandatory in my area.

Lower Your Diabetes Risk
Global Awareness, Healthcare, MedHeads

Lower Your Diabetes Risk by 36%

A new study finds people who consume two servings of fruit per day have 36 percent lower odds of developing type 2 diabetes than those who consume less than half a serving. The research was published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

Diabetes is a disease where people have too much sugar in their bloodstream, and it is a huge public health burden. Approximately 463 million adults worldwide were living with diabetes in 2019, and by 2045 this number is expected to rise to 700 million. An estimated 374 million people are at increased risk of developing type 2 diabetes, the most common form of the disease. A healthy diet and lifestyle can play a major role in lowering a person’s diabetes risk.

“We found people who consumed around 2 servings of fruit per day had a 36 percent lower risk of developing type 2 diabetes over the next five years than those who consumed less than half a serving of fruit per day,” said study author Nicola Bondonno, Ph.D., of Edith Cowan University’s Institute for Nutrition Research in Perth, Australia. “We did not see the same patterns for fruit juice. These findings indicate that a healthy diet and lifestyle which includes the consumption of whole fruits is a great strategy to lower your diabetes risk.”

The researchers studied data from 7,675 participants from the Baker Heart and Diabetes Institute’s Australian Diabetes, Obesity and Lifestyle Study who provided information on their fruit and fruit juice intake through a food frequency questionnaire. They found participants who ate more whole fruits had 36 percent lower odds of having diabetes at five years. The researchers found an association between fruit intake and markers of insulin sensitivity, meaning that people who consumed more fruit had to produce less insulin to lower their blood glucose levels.

“This is important because high levels of circulating insulin (hyperinsulinemia) can damage blood vessels and are related not only to diabetes, but also to high blood pressure, obesity and heart disease,” Bondonno said.

Reference: Bondonno NP, Davey RJ, Murray K, et al. Associations between fruit intake and risk of diabetes in the AusDiab cohort. J. Clin. Endocrinol. Metab. 2021;(dgab335). doi: 10.1210/clinem/dgab335

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Food Addiction
Global Awareness, Healthcare, MedHeads

Food Addiction

Binge eating disorder was a diagnosis formulated in the Diagnostic Statistical Manual, 5th edition (DSM5) and represents a step forward towards the formal recognition of food addiction. This term itself is now rendered problematic by DSM5’s change from the term addiction to the term substance use disorder.

The advent of DSM5 has heralded a re-evaluation of the diagnosis of food addiction. The following criteria for food addiction have been proposed as modifications of the current DSM5 criteria for substance use disorder

1. Food often consumed in larger amounts or over a longer period than was intended

2. Persistent desire of unsuccessful efforts to cut down or control food intake

3. Great deal of time is spent in activities necessary to obtain or overeat on foods or recover from its effects

4. Craving, or a strong desire or urge to eat specific foods

5. Recurrent overeating resulting in a failure to fulfill major role obligations at work, school, or home

6. Continued overeating despite having persistent or recurrent social or interpersonal problems causes or exacerbated by the effects of specific foods

7. Important social, occupational, or recreational activities are given up or reduced because of overeating on foods

8. Recurrent overeating in situations in which it is physically hazardous

9. Overeating is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by overeating on foods

10. Tolerance defined as a need for markedly increased amounts of food to achieve desired effect or a markedly diminished effect with continued use of the same amount of food

11. Withdrawal defined as a withdrawal syndrome when refraining from eating specific foods or when specific foods are eaten to relieve or avoid withdrawal symptoms

The diagnosis of food addiction according to the above would require the presence of at least two symptoms, however, one of the criticisms of this rubric is the potential for overdiagnosis of food addiction, especially when one considers that non-obese patients who struggle with the cycle of overeating and dieting may endorse at least two criteria.

The Yale Food Addiction Scale version 2 (YFAS2) has been developed as a tool for the diagnosis of food addiction. It has thirty-five questions which are based on the current eleven substance use disorder criteria described by DSM5.

Obesity, food addiction and binge eating disorders can be seen to be closely related, but nonetheless distinct clinical entities each with their own diagnostic criteria.

Obesity is diagnosed when the body mass index is more than 30 kg/m2. Binge eating disorder is diagnosed when binges (consumption of large amounts of food in a limited time frame such as two hours) occur at least weekly for the last three months and where these binges are associated with a loss of control of eating and significant distress to the patient.

Using the YFAS2 the prevalence of food addiction in those with obesity ranges from 20-50%, in those with anorexia nervosa, 70% in those with anorexia nervosa, 80% in those with binge eating disorder and 95% in those with bulimia nervosa.

Therefore, the management of both obesity and binge eating disorder can be approached from the perspective of addiction treatment. Such paradigms already exist, e.g., “Food Addicts In Recovery Anonymous”. Whilst medication can play a role in the management of these conditions it is important to understand, identify and manage the underlying psychological issues that predispose to and perpetuate these food related behaviours. Failure to do so results in an ongoing cycle of emotionally driven overeating and self-loathing.

What is Lifestyle Medicine
Global Awareness, Healthcare, MedHeads

What is Lifestyle Medicine

The American College of Lifestyle Medicine defines lifestyle medicine as
“the use of evidence-based lifestyle therapeutic intervention—including a whole-food, plant-predominant eating pattern, regular physical activity, restorative sleep, stress management, avoidance of risky substances, and positive social connection—as a primary modality, delivered by clinicians trained and certified in this specialty, to prevent, treat, and often reverse chronic disease”

But what does it mean in practice? I think of lifestyle medicine as the management of chronic diseases within a socio-psycho-bio-medical framework that incorporates the three Fs and the three Ss.

What is the socio-psycho-bio-medical approach I hear you say?

This approach to chronic disease management considers all aspects of a person’s care including social supports, psychological therapies, biological therapies and medical interventions. It emphasises the role of lifestyle but does not replace or exclude appropriate pharmaceutical or surgical management of chronic diseases.

What are the three Fs and the three Ss? They are the following.

Feet
Fork
Fingers

Sleep
Stress management
Socialisation

Feet
Feet reminds us to consider exercise as a lifestyle medicine intervention. It is recommended for most adults that they engage in at least 150 minutes of brisk walking (or equivalent exercise) per week.

Fork
Fork reminds us to consider diet as part of a lifestyle intervention. As per the definition above, a lifestyle medicine practitioner would recommend a whole-food, plant-predominant eating pattern to maintain a normal weight and nutritional balance.

Fingers
Fingers remind us to consider abstinence from cigarettes and other illicit drugs. They also remind us to limit alcohol intake to no more than ten units per week and no more than four units on any given day.

Sleep
This reminds us that most adults need between seven to nine hours of sleep per night. The days of the sleep-deprived hero are over. Evidence now demonstrates the health benefits of a good night’s sleep which one dismisses at one’s peril.

Stress
Stress is known to contribute to and exacerbate the burden of chronic disease. Stress management interventions should be incorporated into any lifestyle medicine plan of care.

Socialisation
Socialisation reminds us that we are social animals designed to engage positively, purposefully, and meaningfully with our tribe. Loneliness is now known to affect chronic diseases and put us at risk of premature death. Treating loneliness and encouraging the development of positive, purposeful, and meaningful social networks is an important part of a lifestyle medicine plan.

Dr Ferghal is both qualified and experienced in the field of lifestyle medicine.

A Difficult Conversation
Cracking Addiction, Global Awareness, Healthcare, MedHeads

A Difficult Conversation

A Difficult Conversation

I hate seeing other doctors regular patients. They have expectations of clinical behaviour of which I am totally ignorant. This lady was no different. I had never met her before. She was middle aged. She ran her own cleaning company.

She breezed in and said to me that phrase that I dread.

“I normally see Dr…This will be quick, I just need a prescription.”

So the conversation went something like this.

“Hello, my Name is Dr Armstrong. How can I help you.”

“Well, I just told you, I just need my usual script.”

“What usual script.”

“I just need my usual Panadeine Forte.”

“may I ask why you need Panadeine Forte?”

“I take it two to three times a week when I cannot sleep. I don’t abuse it. Dr… always gives me some.”

I checked safe script. She was right. Dr … was regularly prescribing it. There were no red flags against her safe script record. It appeared that Dr…was prescribing only small quantities of the drug and no alarms had been triggered in the SafeScript software.

I then asked her, “So you use it to help you sleep, is that right?”

“Yes, I’ve just told you, now please give me the prescription. I am in a hurry.”

She then looked at her watch meaningfully.

I explained to her that I felt that it was my role to manage her appropriately and safely. I explained that I felt that her use of codeine was inappropriate and that it could lead to dependency. I offered to help her deal with her insomnia in a more holistic way.

She then said, “Look Doc. You are being difficult. Are you, or are you not going to prescribe Panadeine Forte for me. Or do I have to go to Dr…?”

I replied, “No I am not.”

“Well you’re a useless waste of space then aren’t you!”

She walked out. An hour later she saw the other doctor. At least he came to me to let me know that he had prescribed for her, on the grounds that her use was not excessive and that a year ago she could have bought it over the counter.

What is a Partial Agonist
Cracking Addiction, Global Awareness, Healthcare

What is a Partial Agonist?

What is a Partial Agonist?

A partial agonist is a drug that, when bound to a receptor, only partially activates that receptor.

This is in contra-distinction to full agonists which, when bound to a receptor, fully activate the receptor. If you look at a dose response curve, in the case of full agonists, as the dose increases so too does the clinical effect. In the case of partial agonists, they behave differently.

At low to moderate doses they behave as functional agonists in that as the dose increases then so too does the clinical effect, albeit at a lower rate when compared with the full agonist curve.

However at high doses they behave as antagonists in that any further dose increase results in no additional clinical effect. Therefore in the case of partial agonists a ceiling effect occurs wherein beyond a certain dose no further effect is seen.

Now, what is this all about? Why am I bothering to write about this?

Well the answer is prescription opioid abuse.

More people died last year from prescription drug misuse than did on the roads in Victoria.

We as doctors are killing our patients with our prescriptions. Prescription opioids play a big part in this mortality. Most clinically used opioids are full mu opioid receptor agonists. Therefore as the dose goes up so too does the risk of respiratory depression and death.

Imagine if there was a drug which was a great pain killer, just like the commonly used opioids, but which was much less likely to cause respiratory depression and death. Wouldn’t you want to use that drug? Wouldn’t you want to at least know more about it?

Well, there is an opioid that is a partial agonist at the mu opioid receptor. Because it is a partial agonist it has a ceiling effect which occurs below the threshold for respiratory depression in most healthy adults. Therefore it is much less likely to cause respiratory depression and death.

Just think about how much safer this drug would be as compared to all the other full mu opioid receptor agonists that are commonly prescribed, including morphine and oxycodone.

I cannot understand why we as doctors are not prescribing more of this safer drug when faced with the horrifying statistics of mortality associated with prescription opioid misuse.

Want to know what this drug is?

It’s called buprenorphine. It comes as a “Norspan” patch, a “Temgesic” sublingual pill, and a “Suboxone” sublingual film.

Scroll to Top